BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38817970)

  • 1. Emodin inhibits respiratory syncytial virus entry by interactions with fusion protein.
    Xiong Y; Tan G; Tao K; Zhou Y; Li J; Ou W; Shen C; Xie T; Zhang C; Hou Y; Ji J
    Front Microbiol; 2024; 15():1393511. PubMed ID: 38817970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibits respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane.
    Tang W; Li M; Liu Y; Liang N; Yang Z; Zhao Y; Wu S; Lu S; Li Y; Liu F
    FASEB J; 2019 Mar; 33(3):4287-4299. PubMed ID: 30571312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein.
    Tang W; Li Y; Song Q; Wang Z; Li M; Zhang Q; Wang Y; Ye W; Li Y
    J Virol; 2021 Sep; 95(20):e0120521. PubMed ID: 34379500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol inhibits respiratory syncytial virus replication by targeting heparan sulfate proteoglycans.
    Xiong Y; Tao K; Li T; Ou W; Zhou Y; Zhang W; Wang S; Qi R; Ji J
    Food Funct; 2024 Feb; 15(4):1948-1962. PubMed ID: 38270052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.
    Leemans A; De Schryver M; Van der Gucht W; Heykers A; Pintelon I; Hotard AL; Moore ML; Melero JA; McLellan JS; Graham BS; Broadbent L; Power UF; Caljon G; Cos P; Maes L; Delputte P
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion protein.
    Razinkov V; Gazumyan A; Nikitenko A; Ellestad G; Krishnamurthy G
    Chem Biol; 2001 Jul; 8(7):645-59. PubMed ID: 11451666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein.
    Meng J; Hotard AL; Currier MG; Lee S; Stobart CC; Moore ML
    J Virol; 2016 Jan; 90(1):245-53. PubMed ID: 26468535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor.
    Sake SM; Zhang X; Rajak MK; Urbanek-Quaing M; Carpentier A; Gunesch AP; Grethe C; Matthaei A; Rückert J; Galloux M; Larcher T; Le Goffic R; Hontonnou F; Chatterjee AK; Johnson K; Morwood K; Rox K; Elgaher WAM; Huang J; Wetzke M; Hansen G; Fischer N; Eléouët JF; Rameix-Welti MA; Hirsch AKH; Herold E; Empting M; Lauber C; Schulz TF; Krey T; Haid S; Pietschmann T
    Nat Commun; 2024 Feb; 15(1):1173. PubMed ID: 38332002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
    Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection.
    Schlender J; Zimmer G; Herrler G; Conzelmann KK
    J Virol; 2003 Apr; 77(8):4609-16. PubMed ID: 12663767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel RSV F-Fc fusion protein vaccine reduces lung injury induced by respiratory syncytial virus infection.
    Zhang Y; Zhou Z; Zhu SL; Zu X; Wang Z; Zhang LK; Wang W; Xiao G
    Antiviral Res; 2019 May; 165():11-22. PubMed ID: 30822450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis.
    Hotard AL; Lee S; Currier MG; Crowe JE; Sakamoto K; Newcomb DC; Peebles RS; Plemper RK; Moore ML
    J Virol; 2015 Jan; 89(1):512-22. PubMed ID: 25339762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficiency of p27 Cleavage during
    Rezende W; Ye X; Angelo LS; Carisey AF; Avadhanula V; Piedra PA
    J Virol; 2023 May; 97(5):e0025423. PubMed ID: 37133390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and evaluation of a novel tribenzamide derivative as an inhibitor targeting the entry of the respiratory syncytial virus.
    Issmail L; Ramsbeck D; Jäger C; Henning T; Kleinschmidt M; Buchholz M; Grunwald T
    Antiviral Res; 2023 Mar; 211():105547. PubMed ID: 36682463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection.
    Stokes KL; Currier MG; Sakamoto K; Lee S; Collins PL; Plemper RK; Moore ML
    J Virol; 2013 Sep; 87(18):10070-82. PubMed ID: 23843644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants.
    Yoshida I; Arikawa K; Honma Y; Inatani S; Yoshinaga M; Sugiyama H
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.
    Perron M; Stray K; Kinkade A; Theodore D; Lee G; Eisenberg E; Sangi M; Gilbert BE; Jordan R; Piedra PA; Toms GL; Mackman R; Cihlar T
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1264-73. PubMed ID: 26666922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein.
    Douglas JL; Panis ML; Ho E; Lin KY; Krawczyk SH; Grant DM; Cai R; Swaminathan S; Cihlar T
    J Virol; 2003 May; 77(9):5054-64. PubMed ID: 12692208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.
    Yan D; Lee S; Thakkar VD; Luo M; Moore ML; Plemper RK
    Proc Natl Acad Sci U S A; 2014 Aug; 111(33):E3441-9. PubMed ID: 25092342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus entry inhibitors targeting the F protein.
    Sun Z; Pan Y; Jiang S; Lu L
    Viruses; 2013 Jan; 5(1):211-25. PubMed ID: 23325327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.